451 related articles for article (PubMed ID: 17001881)
1. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
Choudhury M; Singh S
Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
[TBL] [Abstract][Full Text] [Related]
2. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
4. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
6. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
[TBL] [Abstract][Full Text] [Related]
7. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
Berlin Grace VM
Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification.
Acay R; Rezende N; Fontes A; Aburad A; Nunes F; Sousa S
Oral Microbiol Immunol; 2008 Aug; 23(4):271-4. PubMed ID: 18582325
[TBL] [Abstract][Full Text] [Related]
9. [Detection of human papillomavirus DNA in cervical cancer tissue by PCR and direct sequencing].
Liu X; Liu GB; Pang ZJ; Xing FQ; Guo SQ; Ma WL; Zheng WL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):201-3. PubMed ID: 15699006
[TBL] [Abstract][Full Text] [Related]
10. Reliability of in-situ hybridization of smears and biopsies for papilloma virus genotyping of the uterine cervix.
Czerwenka KF; Schön HJ; Manavi M; Zeillinger R; Kubista E; Gitsch E
Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):139-45. PubMed ID: 1646655
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization.
Cheung AL; Graf AH; Hauser-Kronberger C; Dietze O; Tubbs RR; Hacker GW
Mod Pathol; 1999 Jul; 12(7):689-96. PubMed ID: 10430273
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas.
Koyama K; Uobe K; Tanaka A
J Oral Pathol Med; 2007 Jan; 36(1):18-24. PubMed ID: 17181737
[TBL] [Abstract][Full Text] [Related]
15. Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods.
Cho NH; Joo HJ; Ahn HJ; Jung WH; Lee KG
Pathol Res Pract; 1998; 194(10):713-20. PubMed ID: 9820868
[TBL] [Abstract][Full Text] [Related]
16. Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of cervical lesions in gynecological patients from Recife, Brazil.
Baldez da Silva MF; Guimarães V; Silva MA; Medeiros do Amaral CM; Beçak W; Stocco RC; Freitas AC; Crovella S
Genet Mol Res; 2012 Mar; 11(1):462-6. PubMed ID: 22427039
[TBL] [Abstract][Full Text] [Related]
17. [Detection and genotyping of human papillomavirus in biopsies of uterine cervical adenocarcinoma].
Brebi M P; Ili G CG; López M J; García M P; Melo A A; Montenegro H S; Leal R P; Guzmán G P; Roa S JC
Rev Med Chil; 2009 Mar; 137(3):377-82. PubMed ID: 19621179
[TBL] [Abstract][Full Text] [Related]
18. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix.
Lorenzon L; Mazzetta F; Venuti A; Frega A; Torrisi MR; French D
J Clin Virol; 2011 Oct; 52(2):79-83. PubMed ID: 21767984
[TBL] [Abstract][Full Text] [Related]
19. The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions.
Giraldo PC; Eleutério J; Cavalcante DI; Gonçalves AK; Romão JA; Eleutério RM
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):88-91. PubMed ID: 17485158
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
